Stay informed with the LNN Daily Newsletter
University of Lethbridge professor Dr. Nehal Thakor has received a $50,000 grant for his research in finding a new therapeutic target for glioblastoma, a deadly brain cancer. (Photo: University of Lethbridge)

University of Lethbridge professor receives funding for brain cancer research

Dec 6, 2023 | 12:16 PM

LETHBRIDGE, AB – A professor at the University of Lethbridge (U of L) is one of two Canadian researchers to earn a grant from the American Brain Tumor Association.

Dr. Nehal Thakor is a professor of chemistry and biochemistry at the U of L. He has received a $50,000 grant for his research in finding a new therapeutic target for glioblastoma, a deadly brain cancer.

The funding is a $50,000 US award from the association, with partial funding coming from the Brain Tumor Foundation of Canada. The one-year grants support high-risk, high-reward innovative approaches that could potentially change existing diagnostic or treatment standards.

Thakor said he is “extremely grateful to receive this funding.”

“Frontline therapeutic agents are failing in the clinic, and there is an urgent need to develop novel therapeutic intervention strategies for treating patients with glioblastoma tumours.”

He added, “This is one of the deadliest cancers and even with surgery, chemotherapy and radiation, the average survival rate is only 15 months.”

Thakor and his research team aim to understand the mechanism that makes glioblastoma such an aggressive type of cancer. The team has identified a protein that allows glioblastoma cells to survive under conditions that normally cause cell death. Thakor’s research will help to validate the protein as a target for therapeutics.

READ MORE: Lethbridge News Now.

If you have a news tip, question or concern, please email Lethbridge.newsroom@Pattisonmedia.com.